Literature DB >> 21661400

Serum LDL-C and LDL-C/HDL-C ratio are positively correlated to lymph node stages in males with colorectal cancer.

Ye-Liu Liu1, Hai-Xin Qian, Lei Qin, Xiao-Jun Zhou, Bo Zhang.   

Abstract

BACKGROUND/AIMS: Although changes in serum lipid profile have been reported in CRC, the specific association between serum lipid profile and lymph node stages remains uncertain.
METHODOLOGY: Fasting serum lipid profile, including TC, TG, HDL-C and LDL-C was retrospectively evaluated in 968 patients undergoing curative resection for primary CRC. To determine the nutritional status, the serum albumin levels were measured and BMI was calculated. Statistical analyses were performed to investigate the association of serum lipid profile with lymph node stages.
RESULTS: Serum lipid levels correlated well with rate of lymph node metastasis and high LDL-C and low HDL-C levels tended to present more advanced lymph node stages. The observed elevation of the LDL-C/HDL-C ratio for patients with N2 stage was statistically significant when compared with patients with N1 stage. When separated by gender, multivariate logistic regression analysis showed that both LDL-C levels and LDL-C/HDL-C ratio had independent association with advanced N2 stage in males, but not in females. In addition, LDL-C/HDL-C ratio might be a more effective biomarker for identifying N2 stage than LDL-C levels alone (OR value: 2.85 vs. 1.63).
CONCLUSIONS: Elevated serum LDL-C levels and an increased LDC-C/HDL-C ratio might favour development of lymph node metastasis and LDCC/HDL-C ratio might be a more effective biomarker for identifying advanced N2 stage than LDL-C levels alone, especially for male patients with CRC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21661400

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Anticancer activity of the cholesterol exporter ABCA1 gene.

Authors:  Bradley Smith; Hartmut Land
Journal:  Cell Rep       Date:  2012-09-13       Impact factor: 9.423

2.  Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.

Authors:  Jie You; Wen-Yue Liu; Gui-Qi Zhu; Ou-Chen Wang; Rui-Min Ma; Gui-Qian Huang; Ke-Qing Shi; Gui-Long Guo; Martin Braddock; Ming-Hua Zheng
Journal:  Oncotarget       Date:  2015-08-14

3.  Identification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agents.

Authors:  Luke Esau; Sunil Sagar; Dhinoth Bangarusamy; Mandeep Kaur
Journal:  Genes Cancer       Date:  2016-09

4.  Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy.

Authors:  Pengxiang Chen; Lihui Han; Cong Wang; Yibin Jia; Qingxu Song; Jianbo Wang; Shanghui Guan; Bingxu Tan; Bowen Liu; Wenqiao Jia; Jianfeng Cui; Wei Zhou; Yufeng Cheng
Journal:  Oncotarget       Date:  2017-06-20

5.  Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).

Authors:  Ting Zhou; Jianhua Zhan; Wenfeng Fang; Yuanyuan Zhao; Yunpeng Yang; Xue Hou; Zhonghan Zhang; Xiaobo He; Yaxiong Zhang; Yan Huang; Li Zhang
Journal:  BMC Cancer       Date:  2017-04-14       Impact factor: 4.430

6.  Differential Tissue Fatty Acids Profiling between Colorectal Cancer Patients with and without Synchronous Metastasis.

Authors:  Maria Notarnicola; Dionigi Lorusso; Valeria Tutino; Valentina De Nunzio; Giampiero De Leonardis; Gisella Marangelli; Vito Guerra; Nicola Veronese; Maria Gabriella Caruso; Gianluigi Giannelli
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

Review 7.  Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.

Authors:  Kush K Patel; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2021-06-12       Impact factor: 5.858

8.  A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C.

Authors:  Fangxin Liao; Wenzhuo He; Chang Jiang; Chenxi Yin; Guifang Guo; Xuxian Chen; Huijuan Qiu; Yuming Rong; Bei Zhang; Dazhi Xu; Liangping Xia
Journal:  Onco Targets Ther       Date:  2015-10-27       Impact factor: 4.147

9.  Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients.

Authors:  Danian Dai; Bo Chen; Bin Wang; Hailin Tang; Xing Li; Zhiping Zhao; Xuan Li; Xiaoming Xie; Weidong Wei
Journal:  J Cancer       Date:  2016-08-07       Impact factor: 4.207

10.  Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population.

Authors:  Yu-Tuan Wu; Qing-Qing Luo; Xin Li; Bilal Arshad; Zhou Xu; Liang Ran; Chun-Xia Zhao; He Wu; Yan-Ling Shi; Hao-Ran Chen; Hao Li; Hong-Yuan Li; Kai-Nan Wu; Ling-Quan Kong
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.